Please try another search
For the fiscal year ended 31 August 2021, Australian Pharmaceutical Industries Ltd revenues decreased less than 1% to A$4.01B. Net income totaled A$1.4M vs. loss of A$7.6M., also reflect New Zealand segment decrease of 10% to A$42.9M, New Zealand segment decrease of 10% to A$42.9M. Net income reflects Australia segment income increase from A$4.8M to A$57.4M, Eliminations segment income increase from A$469K to A$5.3M.
Period Ending: | Aug 31, 2021 | Feb 28, 2021 | Aug 31, 2020 | Feb 29, 2020 |
---|---|---|---|---|
Total Revenue | 2025.46 | 1981.45 | 1988.8 | 2036.17 |
Gross Profit | 245.52 | 251.05 | 221.62 | 258.32 |
Operating Income | -1.57 | 29.42 | -33.69 | 39.3 |
Net Income | -14.49 | 15.87 | -29.32 | 21.76 |
Period Ending: | Aug 31, 2021 | Feb 28, 2021 | Aug 31, 2020 | Feb 29, 2020 |
---|---|---|---|---|
Total Assets | 1529.94 | 1505.56 | 1540 | 1658.97 |
Total Liabilities | 1091.13 | 1045.17 | 1089.07 | 1153.99 |
Total Equity | 438.81 | 460.4 | 450.92 | 504.98 |
Period Ending: | Aug 31, 2021 | Feb 28, 2021 | Aug 31, 2020 | Feb 29, 2020 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | 71.8 | -22.29 | 215.51 | 111.47 |
Cash From Investing Activities | -68.92 | -51.14 | 51.13 | 66.75 |
Cash From Financing Activities | -36.78 | 58.05 | -238.85 | -143.5 |
Net Change in Cash | -34.01 | -15.38 | 27.82 | 34.72 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review